Plain-English translation of NCT06260358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new structured report format designed to help doctors stage cervical cancer more consistently and accurately. The report is based on the standard staging system used worldwide (FIGO staging). By involving multiple doctors in reviewing these reports, the researchers believe they can reduce confusion and improve how patients are treated.
Right now, different doctors may stage cervical cancer differently based on the same information, which can lead to inconsistent treatment plans. This study aims to create a clearer, more uniform reporting system that ensures all patients receive consistent and appropriate care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow the research team to review your medical records, imaging scans (MRI), and cancer staging information. Doctors from different specialties (a multidisciplinary team) would evaluate your case using the new structured report format to see how well it works. You would not receive a new treatment—the study focuses on improving how doctors document and communicate your cancer stage.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Italy
Enrollment target
~30 participants
Started
March 2024
Primary completion
March 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Russo Luca
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.